Return to Today's science sparks archives

2008-07-01

Fig 2a. Results of 2880 Compound Library Screen. Scale bar corresponds to 80 micrometer.

Fig 2a. Results of 2880 Compound Library Screen. Scale bar corresponds to 80 micrometer.
  • Desbordes SC, Placantonakis DG, Ciro A, Socci ND, Lee G, Djaballah H, Studer L

  • Cell Stem Cell.2008 Jun 5;2(6):602-12.

2008-07-02

Fig 1.  Preoperative CT scan of the case patient.

Fig 1. Preoperative CT scan of the case patient.
  • Masterson TA, Russo P

  • Nat Clin Pract Urol.2008 Jun;5(6):345-9.

2008-07-03

Fig 2a. In non-neoplastic renal tissue adjacent to tumor, PSMA was exclusively expressed in the epithelial cells of the proximal tubules and absent in native renal vessels, glomeruli and stroma.

Fig 2a. In non-neoplastic renal tissue adjacent to tumor, PSMA was exclusively expressed in the epithelial cells of the proximal tubules and absent in native renal vessels, glomeruli and stroma.
  • Al-Ahmadie HA, Olgac S, Gregor PD, Tickoo SK, Fine SW, Kondagunta GV, Scher HI, Morris MJ, Russo P, Motzer RJ, Reuter VE

  • Mod Pathol.2008 Jun;21(6):727-32.

2008-07-07

Fig 5. Dcr-2- and AGO2-Deficient Cells Exhibit Increased Levels of TE Transcripts. Relative RNA levels (mean ± SD) are shown.(A) TE transcripts were measured by quantitative RT-PCR of S2 cells treated with dsRNA against Dcr-2 or AGO2, normalized to GFP dsRNA-treated cells.

Fig 5. Dcr-2- and AGO2-Deficient Cells Exhibit Increased Levels of TE Transcripts. Relative RNA levels (mean ± SD) are shown.(A) TE transcripts were measured by quantitative RT-PCR of S2 cells treated with dsRNA against Dcr-2 or AGO2, normalized to GFP dsRNA-treated cells.
  • Chung WJ, Okamura K, Martin R, Lai EC

  • Curr Biol.2008 Jun 3;18(11):795-802.

2008-07-08

Fig. 5. Coronal representation of a patient with thymic carcinoma treated with sequential tomotherapy IMRT.

Fig. 5. Coronal representation of a patient with thymic carcinoma treated with sequential tomotherapy IMRT.
  • Fuller CD, Housman DM, Thomas CR

  • Hematol Oncol Clin North Am.2008 Jun;22(3):489-507.

2008-07-09

Fig 2. Each nucleotide triplet is bound by three consecutive RecA protomers.

Fig 2. Each nucleotide triplet is bound by three consecutive RecA protomers.
  • Chen Z, Yang H, Pavletich NP

  • Nature. 2008 May 22;453(7194):489-4.

2008-07-10

Fig. 1 The figure shows the typical radiographic appearance of low-grade juxtacortical osteogenic sarcoma demonstrating a lobulated ossific mass on the surface of the bone.

Fig. 1 The figure shows the typical radiographic appearance of low-grade juxtacortical osteogenic sarcoma demonstrating a lobulated ossific mass on the surface of the bone.
  • Schwab JH, Antonescu CR, Athanasian EA, Boland PJ, Healey JH, Morris CD

  • Clin Orthop Relat Res. 2008 Jun;466(6):1318-22.

2008-07-11

Fig 6d. A schematic model of brown fat determination by PRDM16.

Fig 6d. A schematic model of brown fat determination by PRDM16.
  • Kajimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas JL, Chin S, Tempst P, Lazar MA, Spiegelman BM

  • Genes Dev. 2008 May 15;22(10):1397-409.

2008-07-14

Fig 2a. Infection of sciatic nerves with wild-type HSV and NV1023.

Fig 2a. Infection of sciatic nerves with wild-type HSV and NV1023.
  • Kelly K, Brader P, Rein A, Shah JP, Wong RJ, Fong Y, Gil Z

  • FASEB J.2008 Jun;22(6):1839-48.

2008-07-15

Fig 8. Differential expression of b2-AR in human prostate specimens.

Fig 8. Differential expression of b2-AR in human prostate specimens.
  • Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Tasken KA

  • Prostate.2008 Jul 1;68(10):1133-42.

2008-07-16

Fig 1b. Promyelocytic leukemia zinc-finger gene (PLZF) is phosphorylated in vivo and in vitro by cyclin-dependent kinase-2 (CDK2).

Fig 1b. Promyelocytic leukemia zinc-finger gene (PLZF) is phosphorylated in vivo and in vitro by cyclin-dependent kinase-2 (CDK2).
  • Costoya JA, Hobbs RM, Pandolfi PP

  • Oncogene.2008 Jun 19;27(27):3789-96.

2008-07-17

Fig 4. CD133 is expressed in differentiated epithelium of normal human colon.

Fig 4. CD133 is expressed in differentiated epithelium of normal human colon.
  • Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S

  • J Clin Invest.2008 Jun;118(6):2111-20.

2008-07-18

Fig 1. Penetrating light is multiply backscattered light; superficial light is singly backscattered light; surface glare is specular reflectance.

Fig 1. Penetrating light is multiply backscattered light; superficial light is singly backscattered light; surface glare is specular reflectance.
  • Pan Y, Gareau DS, Scope A, Rajadhyaksha M, Mullani NA, Marghoob AA

  • Arch Dermatol.2008 Jun;144(6):828-9.

2008-07-21

Fig 4a. MVD is disrupted during CL regression. MVD was assessed by staining with CD31 antibody.

Fig 4a. MVD is disrupted during CL regression. MVD was assessed by staining with CD31 antibody.
  • Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS, Rueda BR

  • Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7670-5.

2008-07-22

Fig 7. Models of MCP-1 and MCP-3 functions in monocyte recruitment process. A, Parallel model. B, Series model.

Fig 7. Models of MCP-1 and MCP-3 functions in monocyte recruitment process. A, Parallel model. B, Series model.
  • Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF, Pamer EG

  • J Immunol. 2008 May 15;180(10):6846-53.

2008-07-23

Fig 1c. Bone marrow samples of CML patients in chronic phase (n = 81) were stained with anti-PML antibody (brown) and anti-CD34 (red). Insets show PML-staining in blasts (B) and differentiated neutrophils (N).

Fig 1c. Bone marrow samples of CML patients in chronic phase (n = 81) were stained with anti-PML antibody (brown) and anti-CD34 (red). Insets show PML-staining in blasts (B) and differentiated neutrophils (N).
  • Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP

  • Nature. 2008 Jun 19;453(7198):1072-8.

2008-07-24

Fig 10e. FDG PET/CT performed on a 50 year old woman with newly diagnosed invasive ductal carcinoma of the right breast with palpable right axillary nodes.

Fig 10e. FDG PET/CT performed on a 50 year old woman with newly diagnosed invasive ductal carcinoma of the right breast with palpable right axillary nodes.
  • Bartella L, Smith CS, Dershaw DD, Liberman L

  • Radiol Clin North Am. 2007 Jan;45(1):45-67.

2008-07-25

Fig 3b. Isodose display for the brain-sparing radiotherapy technique.

Fig 3b. Isodose display for the brain-sparing radiotherapy technique.
  • Wolden SL, Barker CA, Kushner BH, Bodduluri H, Della-Biancia C, Kramer K, Modak S, Cheung NK

  • Pediatr Blood Cancer. 2008 Jun;50(6):1163-8.

2008-07-28

Fig 4. Sequence and Structural Features of Mammalian and Invertebrate Mirtrons.

Fig 4. Sequence and Structural Features of Mammalian and Invertebrate Mirtrons.
  • Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC

  • Mol Cell. 2007 Oct 26;28(2):328-36.

2008-07-29

Fig 6. Nectin-1 and E-cadherin IHC, and hematoxylin and eosin (H and E) staining of HNSCC.

Fig 6. Nectin-1 and E-cadherin IHC, and hematoxylin and eosin (H and E) staining of HNSCC.
  • Yu Z, Adusumilli PS, Eisenberg DP, Darr E, Ghossein RA, Li S, Liu S, Singh B, Shah JP, Fong Y, Wong RJ

  • Mol Ther. 2007 Jan;15(1):103-13.

2008-07-30

Fig. 5D The percentage of tumor-bearing animals with a specific tumor type is plotted for the indicated genotype.

Fig. 5D The percentage of tumor-bearing animals with a specific tumor type is plotted for the indicated genotype.
  • Stracker TH, Couto SS, Cordon-Cardo C, Matos T, Petrini JH

  • Mol Cell. 2008 Jul 11;31(1):21-32.

2008-08-01

Fig 5b. Telomere dysfunction in bone marrow of POT1b+/ñmTRñ/ñ mice.

Fig 5b. Telomere dysfunction in bone marrow of POT1b+/ñmTRñ/ñ mice.
  • Hockemeyer D, Palm W, Wang RC, Couto SS, de Lange T

  • Genes Dev. 2008 Jul 1;22(13):1773-85.

2008-08-04

Fig 2a. Significant linkage disequilibrium in the region at 6q22.33 associating with breast cancer in AJs.

Fig 2a. Significant linkage disequilibrium in the region at 6q22.33 associating with breast cancer in AJs.
  • Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K

  • Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5.

2008-08-05

Fig 4c. Small cell lung cancer of the left pulmonary hilum with an adjacent satellite lung nodule.

Fig 4c. Small cell lung cancer of the left pulmonary hilum with an adjacent satellite lung nodule.
  • Quaia E, Krug LM, Pandit-Taskar N, Nagel A, Reuter VE, Humm J, Divgi C

  • Eur J Radiol. 2008 Aug;67(2):292-9.

2008-08-06

Fig 6b. Silvestrol synergizes with doxorubicin to induce apoptosis in

Fig 6b. Silvestrol synergizes with doxorubicin to induce apoptosis in
  • Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, Porco JA Jr, Pelletier J

  • J Clin Invest. 2008 Jul;118(7):2651-60.

2008-08-07

Fig 3a. 18F-FDG PET images of pelvis show intense 18F-FDG uptake within known cervical tumor at site of cervical mass seen on CT.

Fig 3a. 18F-FDG PET images of pelvis show intense 18F-FDG uptake within known cervical tumor at site of cervical mass seen on CT.
  • Lewis JS, Laforest R, Dehdashti F, Grigsby PW, Welch MJ, Siegel BA

  • J Nucl Med. 2008 Jul;49(7):1177-82.

2008-08-08

Fig 2. All biopsy specimens demonstrated similar changes: mild acanthosis, no hyperkeratosis, basilar hyperpigmentation, and scattered melanophages in papillary dermis.

Fig 2. All biopsy specimens demonstrated similar changes: mild acanthosis, no hyperkeratosis, basilar hyperpigmentation, and scattered melanophages in papillary dermis.
  • Sceppa JA, Smith BL, Marghoob AA, Gottlieb GJ

  • J Am Acad Dermatol. 2008 Aug;59(2 Suppl 1):S33-4.

2008-08-11

Fig 11. Leptomeningeal PCNSL.

Fig 11. Leptomeningeal PCNSL.
  • Haque S, Law M, Abrey LE, Young RJ

  • Radiol Clin North Am. 2008 Mar;46(2):339-61.

2008-08-12

Fig 2.  Quantitative analysis by BLI of adoptively transferred T-cell persistence and tumor progression in individual animals.

Fig 2. Quantitative analysis by BLI of adoptively transferred T-cell persistence and tumor progression in individual animals.
  • Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, Cai S, Pillarsetty N, Hricak H, Sadelain M, Ponomarev V

  • J Nucl Med. 2008 Jul;49(7):1162-70.

2008-08-13

Fig 3. 60-year-old woman with diffuse disease and calcifications in left anterior descending coronary artery (LAD) (arrow) extending into left circumflex artery.

Fig 3. 60-year-old woman with diffuse disease and calcifications in left anterior descending coronary artery (LAD) (arrow) extending into left circumflex artery.
  • Rademaker J, Schˆder H, Ariaratnam NS, Strauss HW, Yahalom J, Steingart R, Oeffinger KC

  • AJR Am J Roentgenol. 2008 Jul;191(1):32-7.

2008-08-14

Fig 18b. Muscle lymphoma on ultrasound. On power Doppler image, the mass is hypervascular.

Fig 18b. Muscle lymphoma on ultrasound. On power Doppler image, the mass is hypervascular.
  • Hwang S

  • Radiol Clin North Am. 2008 Mar;46(2):379-96.

2008-08-15

Fig 1. Structural insights to TopIB transesterification chemistry.

Fig 1. Structural insights to TopIB transesterification chemistry.
  • Yakovleva L, Chen S, Hecht SM, Shuman S

  • J Biol Chem. 2008 283(23):16093-103.

2008-08-18

Fig 1d. Adenocarcinoma, histology. Mucinous BAC. The alveolar walls are slightly thickened by fibrosis and chronic inflammation and they are lined by tall columnar cells with basally oriented nuclei and abundant mucin-filled apical cytoplasm (case showed KRAS mutation).

Fig 1d. Adenocarcinoma, histology. Mucinous BAC. The alveolar walls are slightly thickened by fibrosis and chronic inflammation and they are lined by tall columnar cells with basally oriented nuclei and abundant mucin-filled apical cytoplasm (case showed KRAS mutation).
  • Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL, Travis WD

  • Am J Surg Pathol. 2008 Jun;32(6):810-27.

2008-08-19

Fig. 5d. Top1cc's induce Brca1-dependent degradation of Top1 without substantial degradation of Pol II. MEF cells of the indicated genotype were treated with 25 µM CPT for the indicated times. Western blotting analyses of Top1 and Pol II. Pol IIa (hypophosphorylated CTD) and Pol IIo (hyperphosphorylated CTD) forms are indicated. Tubulin was used as a loading control. The top panel shows quantification of Top1 expression shown.

Fig. 5d. Top1cc's induce Brca1-dependent degradation of Top1 without substantial degradation of Pol II. MEF cells of the indicated genotype were treated with 25 µM CPT for the indicated times. Western blotting analyses of Top1 and Pol II. Pol IIa (hypophosphorylated CTD) and Pol IIo (hyperphosphorylated CTD) forms are indicated. Tubulin was used as a loading control. The top panel shows quantification of Top1 expression shown.
  • Sordet O, Larochelle S, Nicolas E, Stevens EV, Zhang C, Shokat KM, Fisher RP, Pommier Y

  • J Mol Biol. 2008 Sep 5;381(3):540-9.

2008-08-21

Fig. 2h. Detection of apoptotic NY-ESO-1-expressing melanoma cells after CHP-NY-ESO-1 vaccination. Double-labeling of tumor cells undergoing apoptosis is shown by localized, yellow fluorescence (g, h). A significant increase in apoptotic melanoma cells was observed after the third vaccination with CHP-NY-ESO-1 (on day 31).

Fig. 2h. Detection of apoptotic NY-ESO-1-expressing melanoma cells after CHP-NY-ESO-1 vaccination. Double-labeling of tumor cells undergoing apoptosis is shown by localized, yellow fluorescence (g, h). A significant increase in apoptotic melanoma cells was observed after the third vaccination with CHP-NY-ESO-1 (on day 31).
  • Tsuji K, Hamada T, Uenaka A, Wada H, Sato E, Isobe M, Asagoe K, Yamasaki O, Shiku H, Ritter G, Murphy R, Hoffman EW, Old LJ, Nakayama E, Iwatsuki K

  • Cancer Immunol Immunother. 2008 Oct;57(10):1429-37.

2008-08-25

Fig. 1 Representative photograph of pancreatic cancer cells demonstrating eGFP expression after vMyxgfp infection with MOI 10.

Fig. 1 Representative photograph of pancreatic cancer cells demonstrating eGFP expression after vMyxgfp infection with MOI 10.
  • Woo Y, Kelly KJ, Stanford MM, Galanis C, Shin Chun Y, Fong Y, McFadden G

  • Ann Surg Oncol. 2008 Aug;15(8):2329-35.

2008-08-26

Fig. 1 Crystal structure of the globular head region of NiV-G.

Fig. 1 Crystal structure of the globular head region of NiV-G.
  • Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB

  • Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9953-8.

2008-08-27

Fig. 5e Stabilization of p27

Fig. 5e Stabilization of p27
  • Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR

  • Cancer Cell. 2008 Aug 12;14(2):146-55.

2008-08-28

Fig. 4 A Three-Cell Model for TGF-β1-Dependent Regulation of T Cells

Fig. 4 A Three-Cell Model for TGF-β1-Dependent Regulation of T Cells
  • Li MO, Flavell RA

  • Cell. 2008 Aug 8;134(3):392-404.

2008-08-29

Fig. 2b. OP conjugation to TFO/LNA restricts OP cleavage activity to a limited number of genomic sites. Colocalization of phosphoH2AX and 53BP1foci, 24 h after OP-19-mer TFO/LNA transfection.

Fig. 2b. OP conjugation to TFO/LNA restricts OP cleavage activity to a limited number of genomic sites. Colocalization of phosphoH2AX and 53BP1foci, 24 h after OP-19-mer TFO/LNA transfection.
  • Cannata F, Brunet E, Perrouault L, Roig V, Ait-Si-Ali S, Asseline U, Concordet JP, Giovannangeli C

  • Proc Natl Acad Sci. 2008 Jul 15;105(28):9576-81.

2008-09-02

Fig. 6E 2-year-old boy who presented with hoarseness and difficulty swallowing.

Fig. 6E 2-year-old boy who presented with hoarseness and difficulty swallowing.
  • D'Ambrosio N, Soohoo S, Warshall C, Johnson A, Karimi S

  • AJR Am J Roentgenol. 2008 Aug;191(2):589-97.

2008-09-04

Fig. 6c COX-2 expression is upregulated in the SCDH of NR1 KO (Cre) mice.

Fig. 6c COX-2 expression is upregulated in the SCDH of NR1 KO (Cre) mice.
  • Cheng HT, Suzuki M, Hegarty DM, Xu Q, Weyerbacher AR, South SM, Ohata M, Inturrisi CE

  • Neuroscience. 2008 Aug 26;155(3):948-58.

2008-09-05

Fig. 1. Histologic appearance of pediatric GIST.

Fig. 1. Histologic appearance of pediatric GIST.
  • Agaram NP, Laquaglia MP, Ustun B, Guo T, Wong GC, Socci ND, Maki RG, DeMatteo RP, Besmer P, Antonescu CR

  • Clin Cancer Res. 2008 May 15;14(10):3204-15.

2008-09-08

Fig 8. Confirmation of novel gains on chromosomes 7q22 and 1q21.2 using fluorescence in situ hybridization (FISH).

Fig 8. Confirmation of novel gains on chromosomes 7q22 and 1q21.2 using fluorescence in situ hybridization (FISH).
  • Antonescu CR, Wu K, Guoliang LX, Cao M, Turpaz Y, Leversha MA, Hubbell E, Maki RG, Miyada CG, Pillai R

  • Cancer Inform. 2008 Mar 27;6: 59-75.

2008-09-09

Fig 7c. Direct intratumoral injection of si-SV1 induces apoptosis and reduces tumor growth in vivo.

Fig 7c. Direct intratumoral injection of si-SV1 induces apoptosis and reduces tumor growth in vivo.
  • Narla G, DiFeo A, Fernandez Y, Dhanasekaran S, Huang F, Sangodkar J, Hod E, Leake D, Friedman SL, Hall SJ, Chinnaiyan AM, Gerald WL, Rubin MA, Martignetti JA

  • J Clin Invest. 2008 Aug;118(8):2711-21.

2008-09-10

Fig 4. Photograph and {gamma}-camera image of 4-quadrant bar phantom, Energy spectrum for 662-keV {gamma}-ray emitted by 137Cs.

Fig 4. Photograph and {gamma}-camera image of 4-quadrant bar phantom, Energy spectrum for 662-keV {gamma}-ray emitted by 137Cs.
  • Zanzonico P

  • J Nucl Med. 2008 Jul;49(7):1114-31.

2008-09-11

Fig. 4c. Assessment of LLC Tumor Volume, Microvessel Density, Necrosis, and Long-Term Tumor Growth in Mice Treated with Paclitaxel or Gemcitabine in Combination with DC101C57BL/6 mice bearing 500 mm3 LLC tumors were treated with paclitaxel (PTX) or gemcitabine (GEM) with or without DC101 administered 24 hr prior to the chemotherapy drug.

Fig. 4c. Assessment of LLC Tumor Volume, Microvessel Density, Necrosis, and Long-Term Tumor Growth in Mice Treated with Paclitaxel or Gemcitabine in Combination with DC101C57BL/6 mice bearing 500 mm3 LLC tumors were treated with paclitaxel (PTX) or gemcitabine (GEM) with or without DC101 administered 24 hr prior to the chemotherapy drug.
  • Shaked Y, Henke E, Roodhart JM, Mancuso P, Langenberg MH, Colleoni M, Daenen LG, Man S, Xu P, Emmenegger U, Tang T, Zhu Z, Witte L, Strieter RM, Bertolini F, Voest EE, Benezra R, Kerbel RS

  • Cancer Cell. 2008 Sep 9;14(3):263-73.

2008-09-12

Fig. 1b. Schematic representation of how to submit trachelectomy margin at the time of frozen-section analysis. Trachelectomy opened after shave showing grossly visible tumor; distance to margin is measured grossly.

Fig. 1b. Schematic representation of how to submit trachelectomy margin at the time of frozen-section analysis. Trachelectomy opened after shave showing grossly visible tumor; distance to margin is measured grossly.
  • Park KJ, Soslow RA, Sonoda Y, Barakat RR, Abu-Rustum NR

  • Gynecol Oncol. 2008 Sep;110(3):316-23.

2008-09-15

Fig 1a. Structural alignment of the BRCT-related region in the T-ag helicase domain with the C-terminal BRCT repeat in 53BP1.

Fig 1a. Structural alignment of the BRCT-related region in the T-ag helicase domain with the C-terminal BRCT repeat in 53BP1.
  • Kumar A, Joo WS, Meinke G, Moine S, Naumova EN, Bullock PA

  • J Virol. 2008 Sep;82(17):8849-62.

2008-09-16

Fig 1c. Skin retracted with a long-stat retractor to avoid skin necrosis secondary to high-dose irradiation.

Fig 1c. Skin retracted with a long-stat retractor to avoid skin necrosis secondary to high-dose irradiation.
  • Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B

  • Br J Surg. 2008 Sep;95(9):1105-10.

2008-09-17

Fig 1c. Immunocytochemistry for skeletal myosin heavy chain (MyHC) expression.

Fig 1c. Immunocytochemistry for skeletal myosin heavy chain (MyHC) expression.
  • Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, ScimË A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM

  • Nature. 2008 Aug 21;454(7207):961-7.

2008-09-18

Fig 2. Histologic examination of the tumor revealed discrete lobules of angiomatous tissue with inflammatory cells to the level of the muscular layer of the lower lip.

Fig 2. Histologic examination of the tumor revealed discrete lobules of angiomatous tissue with inflammatory cells to the level of the muscular layer of the lower lip.
  • Wang SQ, Goldberg LH

  • Dermatol Surg. 2008 Aug;34(8):1115-6.

2008-09-19

Fig. 1. Transformation with plasmids carrying wild type (wt) human CHEK2, as well as the Y424H variant, represses the normally reduced viability due to Rad53 deletion in the Rad53-null sml1-null yeast S. cerevisiae.

Fig. 1. Transformation with plasmids carrying wild type (wt) human CHEK2, as well as the Y424H variant, represses the normally reduced viability due to Rad53 deletion in the Rad53-null sml1-null yeast S. cerevisiae.
  • Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA, Aloyz R, Nelson PS, Hood L, Narod SA, White KA, Ostrander EA, Isaacs WB, Offit K, Cooney KA, Stanford JL, Foulkes WD

  • Cancer Lett. 2008 Oct 18;270(1):173-180.

2008-09-22

Fig 2. Structural homology between Clp1 and T4 Pnk.

Fig 2. Structural homology between Clp1 and T4 Pnk.
  • Ramirez A, Shuman S, Schwer B

  • RNA. 2008 Sep;14(9):1737-45.

2008-09-23

Fig 8a. siRNA-mediated depletion of hChlR1, Fen1, or Scc1 leads to defects in sister chromatid pairing.

Fig 8a. siRNA-mediated depletion of hChlR1, Fen1, or Scc1 leads to defects in sister chromatid pairing.
  • Farina A, Shin JH, Kim DH, Bermudez VP, Kelman Z, Seo YS, Hurwitz J

  • J Biol Chem. 2008 Jul 25;283(30):20925-36.

2008-09-24

Fig 1d. Fusion protein expression in transiently tranfected Cos7 cells and stably transfected R3327-CD/mDsRed or R3327-CD/UPRT/mDsRed cells

Fig 1d. Fusion protein expression in transiently tranfected Cos7 cells and stably transfected R3327-CD/mDsRed or R3327-CD/UPRT/mDsRed cells
  • Xing L, Deng X, Kotedia K, Ackerstaff E, Ponomarev V, Clifton Ling C, Koutcher JA, Li GC

  • Acta Oncol. 2008;47(7):1211-20.

2008-09-25

Fig. 3b. Covariation of CD8 and SHP-1 levels limits the frequencies of hypo- and hyperresponsive cells. Computer model for T cell activation demonstrate how the EC50 for ppERK responsiveness is determined by both CD8 and SHP-1 levels.

Fig. 3b. Covariation of CD8 and SHP-1 levels limits the frequencies of hypo- and hyperresponsive cells. Computer model for T cell activation demonstrate how the EC50 for ppERK responsiveness is determined by both CD8 and SHP-1 levels.
  • Xing L, Deng X, Kotedia K, Ackerstaff E, Ponomarev V, Clifton Ling C, Koutcher JA, Li GC

  • Science. 2008 Aug 22;321(5892):1081-4.

2008-09-26

Fig 1. Orthogonal film based implant evaluation. Surgical clips identified for cavity delineation and dummy sources were placed in catheters for subsequent position digitization.

Fig 1. Orthogonal film based implant evaluation. Surgical clips identified for cavity delineation and dummy sources were placed in catheters for subsequent position digitization.
  • Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R, White J, Hanson WF, Wilenzick RM, McCormick B

  • Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):467-73.

2008-09-29

Fig 1. Domain organization of M. smegmatis UvrD2.

Fig 1. Domain organization of M. smegmatis UvrD2.
  • Sinha KM, Stephanou NC, Unciuleac MC, Glickman MS, Shuman S

  • Biochemistry. 2008 Sep 9;47(36):9355-64.

2008-09-30

Fig 3b. Adipose tissue response to leptin treatment and withdrawal.

Fig 3b. Adipose tissue response to leptin treatment and withdrawal.
  • Birsoy K, Soukas A, Torrens J, Ceccarini G, Montez J, Maffei M, Cohen P, Fayzikhodjaeva G, Viale A, Socci ND, Friedman JM

  • Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12985-90.

2008-10-01

Fig 8. Schematic representation of the pathway described in the study.

Fig 8. Schematic representation of the pathway described in the study.
  • Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP

  • J Clin Invest. 2008 Sep;118(9):3065-74.